Translating In Silico Predictions into Human Dose Feasibility in AI-Driven Antibacterial Discovery: A Conceptual Pharmacokinetic/Pharmacodynamic Framework
IIAR Journal of Pharmaceutical Sciences · 27.10.2026 · 1 (1)
DOI: 10.68854/fbyysq04 ↗Kurz gefasst
Fachartikel in der Zeitschrift IIAR Journal of Pharmaceutical Sciences, online erschienen am 27.10.2026. Verfasst von Igwe Emmanuel Sunday und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sunday, I. E., Chibueze, U. S., & Usulor, N. E. (2026). Translating In Silico Predictions into Human Dose Feasibility in AI-Driven Antibacterial Discovery: A Conceptual Pharmacokinetic/Pharmacodynamic Framework. IIAR Journal of Pharmaceutical Sciences, 1(1). https://doi.org/10.68854/fbyysq04
Vancouver
Sunday IE, Chibueze US, Usulor NE. Translating In Silico Predictions into Human Dose Feasibility in AI-Driven Antibacterial Discovery: A Conceptual Pharmacokinetic/Pharmacodynamic Framework. IIAR Journal of Pharmaceutical Sciences. 2026;1(1). doi:10.68854/fbyysq04
BibTeX
@article{Sunday2026,
author = {Sunday, Igwe Emmanuel and Chibueze, UDEH Samuel and Usulor, NWOGBOJI Emmanuel},
title = {Translating In Silico Predictions into Human Dose Feasibility in AI-Driven Antibacterial Discovery: A Conceptual Pharmacokinetic/Pharmacodynamic Framework},
journal = {IIAR Journal of Pharmaceutical Sciences},
year = {2026},
volume = {1},
number = {1},
doi = {10.68854/fbyysq04}
}
EUVIMED